RenaSci provides a wide range of innovative in vitro, ex vivo and in vivo CNS techniques used to determine the mode of action, efficacy and side-effect profile of centrally acting drugs. These innovative CNS techniques can be used to assist the biotech and pharmacological industry in developing drugs to treat a range of central nervous system disorders including schizophrenia, attention deficit hyperactivity disorder (ADHD), binge-eating disorder and substance abuse disorder.



Get in touch to find out more.

Contact us

For more details or information on how we can support your project please complete the contact form.